Jagsonpal Pharmaceuticals Limited
NSE: JAGSNPHARM | Information Technology
Market Fundamentals
Stock Intelligence & News
Jagsonpal Services Ltd (530601)
Disclosure of unaudited financial results for the quarter ended 30th June, 2026 published in newspapers.
Read Full Analysis →Jagsonpal Pharmaceuticals Ltd (507789)
Newspaper Advertisement- 47th Annual General Meeting of the Company to be held on September 18, 2026
Read Full Analysis →Jagsonpal Services Ltd (530601)
Disclosure of notice published in newspapers informing about special window opened for re-lodgment of share transfer & demat requests of physical share certificates.
Read Full Analysis →AI-Powered Alerts for Your Portfolio
Alerfo's AI classifies every news event by type, severity, and market impact — then instantly notifies you via Email & WhatsApp only for the stocks you track.
Jagsonpal Pharmaceuticals Limited
Board Meeting Intimation |Meeting Date: 29-Jul-2026
Read Full Analysis →Jagsonpal Pharmaceuticals Limited
Financial Results |Meeting Date: 29-Jul-2026
Read Full Analysis →Jagsonpal Pharmaceuticals Limited
Jagsonpal Pharmaceuticals Limited has informed the Exchange regarding 'Updates on Acquisition of Aequitas Healthcare Private Limited'. |SUBJECT: Updates
Read Full Analysis →Jagsonpal Pharmaceuticals Limited
Jagsonpal Pharmaceuticals Limited has informed the Exchange regarding 'Updates on Acquisition of Aequitas Healthcare Private Limited'. |SUBJECT: Updates
Read Full Analysis →Jagsonpal Pharmaceuticals Limited
Jagsonpal Pharmaceuticals Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. |SUBJECT: Disclosure under SEBI Takeover Regulations
Read Full Analysis →Watch out for these 15 companies, including 4 banks, in today’s trade
HDFC Bank, Yes Bank, Axis Bank, Bandhan Bank, RailTel Corp, Jagsonpal Pharmaceuticals, SIS Limited, BSE, Oberoi Realty, RITES, Accord Transformers & Switchgear, WeWork India, ARSS Infrastructure Projects, Schneider Electric stocks to be in focus today
Read Full Analysis →Jagsonpal Pharmaceuticals Limited
Infinity Holdings has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. |SUBJECT: Disclosure under SEBI Takeover Regulations
Read Full Analysis →Get instant alerts when JAGSNPHARM breaks news
Join investors who track Jagsonpal Pharmaceuticals Limited on Alerfo — free plan available.
Set Free Alert →Frequently Asked Questions
What is the current trend for JAGSNPHARM?
JAGSNPHARM is currently showing a volatility profile consistent with its sector peers, with sentiment being actively monitored by Alerfo news scanners.
How can I set alerts for Jagsonpal Pharmaceuticals Limited?
You can set real-time price and news alerts by registering on the Alerfo platform and adding JAGSNPHARM to your custom watchlist.